Clinical Trials Logo

Filter by:
NCT ID: NCT03250624 Completed - Atopic Dermatitis Clinical Trials

Safety and Efficacy of CD5024 0.3% Cream in Subjects With Atopic Dermatitis

Start date: November 1, 2016
Phase: Phase 2
Study type: Interventional

Exploratory, multi-centric, randomized, vehicle-controlled, investigator-blind, parallel group study, involving subjects with chronic lesions of AD to evaluate the local and systemic safety of CD5024 0.3% cream over a 6-week treatment period compared to its vehicle.

NCT ID: NCT03249727 Recruiting - Colorectal Cancer Clinical Trials

Analysis of Natural Killer Cell Activity (NKA) in Whole Blood in High Risk Subjects Undergoing Colonoscopy

ANKA-HR
Start date: July 5, 2017
Phase: N/A
Study type: Interventional

This study will measure the activity of natural killer (NK) cells using the in vitro diagnostic device NK Vue in high risk subjects (Quebec risk categories P3 and P4) scheduled for colonoscopy.

NCT ID: NCT03249428 Not yet recruiting - Tobacco Dependence Clinical Trials

E-Cigarette Inner City RCT

Start date: September 2017
Phase: N/A
Study type: Interventional

Tobacco is the most preventable cause of disease and death in Canada. Although the tobacco use rate has substantially gone down in the general population, significant differences exist between sub-populations in Canada, for example Ottawa's highly vulnerable homeless or at-risk for homelessness population has an almost 100% tobacco smoking rate relative to 9-18% in the rest of the Canadian general population. This stark inequity in tobacco use translates into devastating healthcare outcomes such as a disproportionate amount of cancer, stroke, heart disease and death. Canadians who are homeless or at-risk for homelessness die 25 years earlier than housed Canadians, mostly due to tobacco. In order to tackle this tobacco use related inequity we urgently need novel approaches. Despite commonly held dogma that People Who Use Drugs (PWUD) don't want to quit smoking, many studies have demonstrated that in fact they are very interested in quitting. Moreover, our pragmatic peer-led community-based action approach used in our PROMPT project has demonstrated that tobacco dependence strategies can be implemented with great success in this population. The majority of PROMPT participants reduced or quit tobacco use, in addition to reducing or quitting all other drug use. Importantly, we have demonstrated that we can gain the trust and engagement of marginalized populations and can create a community space that is low-threshold, safe and non-judgmental. We aim to compare two tobacco dependence management strategies in the homeless (or at-risk for homelessness) multi-drug use population in Ottawa and Toronto. We will use the same peer-led approach in PROMPT with community peer researchers with lived experience. We hope that the cost-effective community based framework derived from this trial will serve as a template for interventions and treatments in community settings for chronic diseases such as obesity and diabetes.

NCT ID: NCT03249311 Recruiting - Clinical trials for None (i.e. Healthy Volunteers)

Levomilnacipran in Healthy Males

Start date: September 1, 2017
Phase: Phase 4
Study type: Interventional

Levomilnacipran is an antidepressant currently approved in Canada to treat Major Depressive Disorder (MDD). Thirty-six healthy male participants will receive escalating doses of levomilnacipran, duloxetine, or placebo every 7 days (+/- 1 day) throughout a 20 - 28 day period. After each dose escalation study participants will be asked to come to the clinic to conduct the necessary tests - these will include tyramine pressor tests as well as blood draws. The results of this study will allow the investigators to determine the dose(s) of levomilnacipran at which reuptake inhibition of norepinephrine and serotonin (chemicals utilized by nerve cells to transmit information to other cells) is achieved.

NCT ID: NCT03249233 Recruiting - Keratoconus Clinical Trials

Corneal Thickness Changes With Scleral Contact Lenses

Start date: June 22, 2017
Phase: N/A
Study type: Interventional

The purpose of this study is to investigate changes in the corneal thickness of scleral contact lens wearers in a keratoconic (KC) population and compare to age-matched controls. The hypothesis is that scleral contact lens wear is associated with low levels of corneal hypoxia including measurable changes in corneal thickness. Corneal thickness will be altered post scleral lens wear compared to pre-lens wear and the amount of alteration will correlate to the fitting characteristics in the central zone of the scleral lenses. We propose to take a sample of keratoconic and control participants, fit them in scleral lenses, and to measure topographic corneal thickness after 8-10 hours of scleral lens wear after two weeks of wear, to compare two instruments in the measurement of corneal thickness, and to compare the effects of varying central corneal clearance of the scleral lens on corneal thickness.

NCT ID: NCT03248921 Recruiting - Obesity Clinical Trials

The Impact of Obesity on Postoperative Outcomes Following Cardiac Surgery

OPOS
Start date: November 2014
Phase: N/A
Study type: Observational

The purpose of this study is to identify measures of obesity, functional capacity, and specific biomarkers that may be predictive of obesity and post-operative outcomes.

NCT ID: NCT03248752 Recruiting - Physical Activity Clinical Trials

Monitoring Physical Activity (Fitbit)

Start date: July 4, 2017
Phase: N/A
Study type: Interventional

The purpose of this study is to examine the effect of monitoring and sharing physical activity outcomes (using Fitbit technology) on physical activity participation in those who have received an exercise prescription from their physician. Primary research question: Does shared physical activity outcomes from wearable technology with a participant's physician improve overall physical activity over 3 months compared to shared outcomes with a family member, unshared outcomes (normal wearable technology condition), and a control group (no wearable technology condition) following an exercise prescription from one's physician? Physical activity will be measured as minutes of moderate to vigorous physical activity per week. Hypothesis: Knowledge that physical activity outcomes will be shared with a participant's physician will serve as a proxy-supervision intervention and improve physical activity adherence in comparison to all other groups. Self- and partner shared outcomes conditions will be more effective than the control group.

NCT ID: NCT03248271 Not yet recruiting - Diabetes Clinical Trials

Effects of Insulin on Hypotension and Sarcopenia

Start date: October 2017
Phase: N/A
Study type: Observational

In this study investigator's aim to determine the impact of insulin therapy on hypotension and sarcopenia

NCT ID: NCT03246802 Not yet recruiting - Clinical trials for Recurrent Prostate Cancer

Partial Prostate Salvage High Dose Rate Brachytherapy

SalvageHDR
Start date: October 1, 2017
Phase: N/A
Study type: Interventional

A dose-response relationship for radiation in the management of prostate cancer is well established. Local recurrence of prostate cancer after external beam radiotherapy occurs in at least 40% of patients treated because of inability to deliver sufficient dose through external beam techniques. These patients respond well to re-irradiation using brachytherapy with about 50% of selected patients remaining free of recurrence 5 years after salvage. Advanced imaging using multiparametric Magnetic Resonance Imaging (mpMRI) allows identification of the site of recurrence, permitting partial prostate salvage brachytherapy. There is extensive literature on Low Dose Rate salvage brachytherapy but less on High Dose Rate.

NCT ID: NCT03246217 Recruiting - Stroke Clinical Trials

Therapeutic Instrumental Music Performance With Sensory-Enhanced Motor Imagery in Chronic Post-Stroke Rehabilitation

Start date: July 20, 2017
Phase: N/A
Study type: Interventional

Research has shown that music engages the brain bilaterally throughout cortical and subcortical regions, accessing extended sensorimotor, cognitive and affective networks. This research explores the hypothesis that use of these shared neural networks allows neurologic music therapy interventions targeting upper extremity motor control to promote plasticity and functional improvements in persons recovering from a cerebrovascular accident. The potential therapeutic benefits of these interventions on attentional processes and affective responding will also be examined.